Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

The Dogs of the Dow 2025 pay big dividends—up to 6.8%! Collectively they yield three-times what the broader market pays.

For the first time in a decade, U.S. obesity rates have begun to decline, raising hopes that the nation may be turning a corner in its battle against the obesity epidemic.

Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...

On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...

For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent ...

Several Hollywood stars, including Jelly Roll, Jessica Simpson and Kathy Bates, showed off dramatic transformations in 2024 after dropping 100 pounds during their weight-loss journey.

At her Thanksgiving table in 2024, half of Ashley Dunham's guests were on a GLP-1 weight loss drug. She made green beans for ...

Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...